Rankings / Hormones & Endocrine
Clascoterone (Winlevi) for hair loss
Hormones & Endocrine · Topical androgen receptor antagonist
Tier B+
Bottom line
Read Off Label grades Clascoterone (Winlevi) for hair loss as B+ (7.1/10) based on moderate evidence, med benefit magnitude, and a low-risk safety profile.
Cassiopea/Sun Pharma.
Typical use: Topical cream/solution to scalp — Rx (approved 2020 for acne as Winlevi); AGA off-label / Phase 2-3.
What this is
Cassiopea/Sun Pharma. FDA-approved 2020 for acne (Winlevi); hair-growth Phase 2 data support an androgenetic-alopecia program, Phase 3 pending. A non-systemic topical anti-androgen, complementary/competitive with pyrilutamide and topical finasteride. Industry-sponsored.
Mechanism
Topical androgen-receptor antagonist (approved for acne) in development for androgenetic alopecia, with local anti-androgen action at the follicle without systemic anti-androgen exposure.
Dose & route
Topical cream/solution to scalp
Citations
Links go to the source. If a link is dead or you want something re-checked, let me know.
Common questions
- Does Clascoterone (Winlevi) for hair loss work?
- Read Off Label rates the evidence for Clascoterone (Winlevi) for hair loss as Moderate and the benefit magnitude as med, producing an overall grade of B+ (7.1/10). Cassiopea/Sun Pharma.
- Is Clascoterone (Winlevi) for hair loss safe?
- Clascoterone (Winlevi) for hair loss has a low risk profile in published human data. Legal status: Rx (approved 2020 for acne as Winlevi); AGA off-label / Phase 2-3. This is not medical advice — see the disclaimer.
- What is the typical dose for Clascoterone (Winlevi) for hair loss?
- Topical cream/solution to scalp
- How does Clascoterone (Winlevi) for hair loss work?
- Topical androgen-receptor antagonist (approved for acne) in development for androgenetic alopecia, with local anti-androgen action at the follicle without systemic anti-androgen exposure.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.